Literature DB >> 21068807

Cognitive remediation therapy needs funding.

Til Wykes1.   

Abstract

Mesh：

Year:  2010        PMID： 21068807     DOI： 10.1038/468165a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  A meta-analysis of cognitive remediation in schizophrenia.

Authors:  Susan R McGurk; Elizabeth W Twamley; David I Sitzer; Gregory J McHugo; Kim T Mueser
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

2.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

3.  Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.

Authors:  Shaun M Eack; Gerard E Hogarty; Raymond Y Cho; Konasale M R Prasad; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Arch Gen Psychiatry       Date:  2010-05-03

4.  One hundred years of schizophrenia: a meta-analysis of the outcome literature.

Authors:  J D Hegarty; R J Baldessarini; M Tohen; C Waternaux; G Oepen
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

5.  A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia.

Authors:  Dwight Dickinson; Wendy Tenhula; Sarah Morris; Clayton Brown; Jason Peer; Katrina Spencer; Lan Li; James M Gold; Alan S Bellack
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

6.  What are we changing with neurocognitive rehabilitation? Illustrations from two single cases of changes in neuropsychological performance and brain systems as measured by SPECT.

Authors:  T Wykes
Journal:  Schizophr Res       Date:  1998-11-09       Impact factor: 4.939

7.  Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.

Authors:  Yasuhiro Kaneda; Karuna Jayathilak; Herbert Y Meltzer
Journal:  Psychiatry Res       Date:  2009-07-30       Impact factor: 3.222

8.  Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.

Authors:  Cameron S Carter; Deanna M Barch; Robert W Buchanan; Ed Bullmore; John H Krystal; Jonathan Cohen; Mark Geyer; Michael Green; Keith H Nuechterlein; Trevor Robbins; Steven Silverstein; Edward E Smith; Milton Strauss; Til Wykes; Robert Heinssen
Journal:  Biol Psychiatry       Date:  2008-05-07       Impact factor: 13.382

9.  Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.

Authors:  D Elie; M Poirier; Jm Chianetta; M Durand; Ca Grégoire; S Grignon
Journal:  J Psychopharmacol       Date:  2009-01-22       Impact factor: 4.153
  9 in total
  6 in total

1.  Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.

Authors:  Richard S E Keefe; Sophia Vinogradov; Alice Medalia; Peter F Buckley; Stanley N Caroff; Deepak C D'Souza; Phillip D Harvey; Karen A Graham; Robert M Hamer; Stephen M Marder; Del D Miller; Stephen J Olson; Jayendra K Patel; Dawn Velligan; Trina M Walker; Adam J Haim; T Scott Stroup
Journal:  J Clin Psychiatry       Date:  2012-05-15       Impact factor: 4.384

2.  Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.

Authors:  Deepak C D'Souza; Rajiv Radhakrishnan; Edward Perry; Savita Bhakta; Nagendra M Singh; Richa Yadav; Danielle Abi-Saab; Brian Pittman; Santosh K Chaturvedi; Mahendra P Sharma; Morris Bell; Chittaranjan Andrade
Journal:  Neuropsychopharmacology       Date:  2012-10-24       Impact factor: 7.853

3.  Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation.

Authors:  Til Wykes; Clare Reeder; Vyv Huddy; Rumina Taylor; Helen Wood; Natalia Ghirasim; Dimitrios Kontis; Sabine Landau
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

4.  Functional Brain Network Characterization and Adaptivity during Task Practice in Healthy Volunteers and People with Schizophrenia.

Authors:  Shennan Aibel Weiss; Danielle S Bassett; Daniel Rubinstein; Tom Holroyd; Jose Apud; Dwight Dickinson; Richard Coppola
Journal:  Front Hum Neurosci       Date:  2011-08-17       Impact factor: 3.169

Review 5.  Thinking about the future cognitive remediation therapy--what works and could we do better?

Authors:  Til Wykes; Will D Spaulding
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Improving functional disability and cognition in Parkinson disease: randomized controlled trial.

Authors:  Javier Peña; Naroa Ibarretxe-Bilbao; Inés García-Gorostiaga; Maria Angeles Gomez-Beldarrain; María Díez-Cirarda; Natalia Ojeda
Journal:  Neurology       Date:  2014-10-31       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.